Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

CBD is effective for certain epilepsy conditions, shows promise for other health issues, but needs more research for safety and effectiveness.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Cox-2 significantly contributes to the development and progression of skin and esophageal cancers.

Y27632 increases cell growth through EGFR signaling, not ROCK1/2.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Hemp shows promise for skincare and hair care due to its therapeutic properties, but standardization and clinical evidence are needed.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The research shows how certain drugs can form stable structures with polymers, which is important for making new pharmaceuticals.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

TCDD reduces EGF receptors in the liver, affecting growth and development.

2-DG reduces seizures by enhancing brain inhibition through specific receptor activation.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Baicalin may help treat severe drug-induced skin reactions.

A new compound effectively inhibits human 5α-reductase 1.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Activating TRPV3 reduces skin oil production and increases inflammation, potentially causing dry skin issues.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Baricitinib effectively treats both rheumatoid arthritis and alopecia areata.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

CBD may help reduce stress and pain in women with PCOS.